Ӱ

Initiatives for Improving Access to Medicines for Non-communicable Diseases

Flexible Pricing Policy in Emerging and Developing Countries

In addition to the patient contribution through innovative new drug development and sales, Ӱ has established a core strategy consisted of affordable pricing, provision of disease solutions, public-private partnerships and local partnerships, to contribute to improving access to medicines in emerging and developing countries.

Approval Status of Global Products

Ӱ strives to bring products to many patients who need them all over the world. Please visit to see the approval status of Ӱ global products in each country and region.